ID GALT9_HUMAN Reviewed; 603 AA. AC Q9HCQ5; Q52LR8; Q6NT54; Q8NFR1; DT 16-AUG-2004, integrated into UniProtKB/Swiss-Prot. DT 03-APR-2007, sequence version 3. DT 24-JAN-2024, entry version 166. DE RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 9; DE EC=2.4.1.41 {ECO:0000269|PubMed:12407114}; DE AltName: Full=Polypeptide GalNAc transferase 9; DE Short=GalNAc-T9; DE Short=pp-GaNTase 9; DE AltName: Full=Protein-UDP acetylgalactosaminyltransferase 9; DE AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9; GN Name=GALNT9; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY. RC TISSUE=Brain; RX PubMed=10978536; DOI=10.1016/s0167-4781(00)00180-9; RA Toba S., Tenno M., Konishi M., Mikami T., Itoh N., Kurosaka A.; RT "Brain-specific expression of a novel human UDP-GalNAc:polypeptide N- RT acetylgalactosaminyltransferase (GalNAc-T9)."; RL Biochim. Biophys. Acta 1493:264-268(2000). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Kidney; RA Guo J.H., Zan Q., Yu L.; RL Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Colon; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY. RX PubMed=12407114; DOI=10.1074/jbc.m203094200; RA Zhang Y., Iwasaki H., Wang H., Kudo T., Kalka T.B., Hennet T., Kubota T., RA Cheng L., Inaba N., Gotoh M., Togayachi A., Guo J.-M., Hisatomi H., RA Nakajima K., Nishihara S., Nakamura M., Marth J.D., Narimatsu H.; RT "Cloning and characterization of a new human UDP-N-acetyl-alpha-D- RT galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp- RT GalNAc-T13, that is specifically expressed in neurons and synthesizes RT GalNAc alpha-serine/threonine antigen."; RL J. Biol. Chem. 278:573-584(2003). CC -!- FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide CC biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a CC serine or threonine residue on the protein receptor. Does not CC glycosylate apomucin or SDC3. {ECO:0000269|PubMed:10978536, CC ECO:0000269|PubMed:12407114}. CC -!- CATALYTIC ACTIVITY: CC Reaction=L-seryl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-O- CC [N-acetyl-alpha-D-galactosaminyl]-L-seryl-[protein] + H(+) + UDP; CC Xref=Rhea:RHEA:23956, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:12788, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:53604, CC ChEBI:CHEBI:58223, ChEBI:CHEBI:67138; EC=2.4.1.41; CC Evidence={ECO:0000269|PubMed:12407114}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-threonyl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3- CC O-[N-acetyl-alpha-D-galactosaminyl]-L-threonyl-[protein] + H(+) + CC UDP; Xref=Rhea:RHEA:52424, Rhea:RHEA-COMP:11060, Rhea:RHEA- CC COMP:11689, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:58223, CC ChEBI:CHEBI:67138, ChEBI:CHEBI:87075; EC=2.4.1.41; CC Evidence={ECO:0000269|PubMed:12407114}; CC -!- COFACTOR: CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; CC -!- PATHWAY: Protein modification; protein glycosylation. CC {ECO:0000269|PubMed:12407114}. CC -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single- CC pass type II membrane protein {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9HCQ5-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9HCQ5-2; Sequence=VSP_011206; CC -!- TISSUE SPECIFICITY: Specifically expressed in brain. Not expressed in CC heart, placenta, lung, liver, skeletal muscle, kidney, pancreas, CC spleen, thymus, prostate, testis, ovary, small intestine, colon and CC leukocyte. In brain, it is expressed in cerebellum, frontal lobe, CC temporal lobe, putamen and spinal cord, weakly expressed in cerebral CC cortex. Not expressed in medulla and occipital pole. CC {ECO:0000269|PubMed:10978536}. CC -!- DOMAIN: There are two conserved domains in the glycosyltransferase CC region: the N-terminal domain (domain A, also called GT1 motif), which CC is probably involved in manganese coordination and substrate binding CC and the C-terminal domain (domain B, also called Gal/GalNAc-T motif), CC which is probably involved in catalytic reaction and UDP-Gal binding. CC {ECO:0000250}. CC -!- DOMAIN: The ricin B-type lectin domain binds to GalNAc and contributes CC to the glycopeptide specificity. {ECO:0000250}. CC -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T CC subfamily. {ECO:0000305}. CC -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase; CC Note=Polypeptide N-acetylgalactosaminyltransferase 9; CC URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_491"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB040672; BAB13699.2; -; mRNA. DR EMBL; AF458594; AAM49722.1; -; mRNA. DR EMBL; BC093817; AAH93817.2; -; mRNA. DR EMBL; BC093819; AAH93819.2; -; mRNA. DR CCDS; CCDS41866.1; -. [Q9HCQ5-2] DR CCDS; CCDS81755.1; -. [Q9HCQ5-1] DR RefSeq; NP_001116108.1; NM_001122636.1. DR RefSeq; NP_068580.2; NM_021808.3. [Q9HCQ5-2] DR AlphaFoldDB; Q9HCQ5; -. DR SMR; Q9HCQ5; -. DR BioGRID; 119094; 53. DR IntAct; Q9HCQ5; 1. DR STRING; 9606.ENSP00000329846; -. DR CAZy; CBM13; Carbohydrate-Binding Module Family 13. DR CAZy; GT27; Glycosyltransferase Family 27. DR GlyCosmos; Q9HCQ5; 1 site, No reported glycans. DR GlyGen; Q9HCQ5; 1 site. DR iPTMnet; Q9HCQ5; -. DR PhosphoSitePlus; Q9HCQ5; -. DR BioMuta; GALNT9; -. DR DMDM; 143811393; -. DR MassIVE; Q9HCQ5; -. DR PaxDb; 9606-ENSP00000380488; -. DR PeptideAtlas; Q9HCQ5; -. DR ProteomicsDB; 81785; -. [Q9HCQ5-1] DR ProteomicsDB; 81786; -. [Q9HCQ5-2] DR Antibodypedia; 32061; 162 antibodies from 21 providers. DR DNASU; 50614; -. DR Ensembl; ENST00000397325.6; ENSP00000380488.2; ENSG00000182870.13. [Q9HCQ5-2] DR Ensembl; ENST00000541995.5; ENSP00000440544.1; ENSG00000182870.13. [Q9HCQ5-2] DR Ensembl; ENST00000671997.1; ENSP00000500654.1; ENSG00000288490.1. [Q9HCQ5-2] DR Ensembl; ENST00000673376.1; ENSP00000500593.1; ENSG00000288490.1. [Q9HCQ5-2] DR GeneID; 50614; -. DR KEGG; hsa:50614; -. DR UCSC; uc001uka.3; human. [Q9HCQ5-1] DR AGR; HGNC:4131; -. DR CTD; 50614; -. DR DisGeNET; 50614; -. DR GeneCards; GALNT9; -. DR HGNC; HGNC:4131; GALNT9. DR HPA; ENSG00000182870; Tissue enriched (brain). DR MIM; 606251; gene. DR neXtProt; NX_Q9HCQ5; -. DR OpenTargets; ENSG00000182870; -. DR PharmGKB; PA28544; -. DR VEuPathDB; HostDB:ENSG00000182870; -. DR eggNOG; KOG3736; Eukaryota. DR GeneTree; ENSGT00940000156599; -. DR HOGENOM; CLU_013477_2_2_1; -. DR InParanoid; Q9HCQ5; -. DR OMA; QYVHRRY; -. DR OrthoDB; 202750at2759; -. DR PhylomeDB; Q9HCQ5; -. DR TreeFam; TF313267; -. DR BRENDA; 2.4.1.41; 2681. DR PathwayCommons; Q9HCQ5; -. DR Reactome; R-HSA-913709; O-linked glycosylation of mucins. DR SignaLink; Q9HCQ5; -. DR UniPathway; UPA00378; -. DR BioGRID-ORCS; 50614; 16 hits in 1139 CRISPR screens. DR ChiTaRS; GALNT9; human. DR GenomeRNAi; 50614; -. DR Pharos; Q9HCQ5; Tbio. DR PRO; PR:Q9HCQ5; -. DR Proteomes; UP000005640; Chromosome 12. DR RNAct; Q9HCQ5; Protein. DR Bgee; ENSG00000182870; Expressed in right hemisphere of cerebellum and 88 other cell types or tissues. DR ExpressionAtlas; Q9HCQ5; baseline and differential. DR GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central. DR GO; GO:0000139; C:Golgi membrane; TAS:Reactome. DR GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IBA:GO_Central. DR GO; GO:0016266; P:O-glycan processing; TAS:Reactome. DR GO; GO:0006493; P:protein O-linked glycosylation; IBA:GO_Central. DR CDD; cd02510; pp-GalNAc-T; 1. DR CDD; cd00161; RICIN; 1. DR Gene3D; 2.80.10.50; -; 1. DR InterPro; IPR045885; GalNAc-T. DR InterPro; IPR001173; Glyco_trans_2-like. DR InterPro; IPR029044; Nucleotide-diphossugar_trans. DR InterPro; IPR035992; Ricin_B-like_lectins. DR InterPro; IPR000772; Ricin_B_lectin. DR PANTHER; PTHR11675; N-ACETYLGALACTOSAMINYLTRANSFERASE; 1. DR PANTHER; PTHR11675:SF28; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 9; 1. DR Pfam; PF00535; Glycos_transf_2; 1. DR Pfam; PF00652; Ricin_B_lectin; 1. DR SMART; SM00458; RICIN; 1. DR SUPFAM; SSF53448; Nucleotide-diphospho-sugar transferases; 1. DR SUPFAM; SSF50370; Ricin B-like lectins; 1. DR PROSITE; PS50231; RICIN_B_LECTIN; 1. DR Genevisible; Q9HCQ5; HS. PE 1: Evidence at protein level; KW Alternative splicing; Disulfide bond; Glycoprotein; Glycosyltransferase; KW Golgi apparatus; Lectin; Manganese; Membrane; Metal-binding; KW Reference proteome; Signal-anchor; Transferase; Transmembrane; KW Transmembrane helix. FT CHAIN 1..603 FT /note="Polypeptide N-acetylgalactosaminyltransferase 9" FT /id="PRO_0000059120" FT TOPO_DOM 1..6 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 7..29 FT /note="Helical; Signal-anchor for type II membrane protein" FT /evidence="ECO:0000255" FT TOPO_DOM 30..603 FT /note="Lumenal" FT /evidence="ECO:0000255" FT DOMAIN 464..600 FT /note="Ricin B-type lectin" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00174" FT REGION 150..261 FT /note="Catalytic subdomain A" FT REGION 318..380 FT /note="Catalytic subdomain B" FT BINDING 191 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 222 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 245 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /evidence="ECO:0000250" FT BINDING 247 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /evidence="ECO:0000250" FT BINDING 377 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /evidence="ECO:0000250" FT BINDING 380 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 385 FT /ligand="substrate" FT /evidence="ECO:0000250" FT CARBOHYD 460 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 141..372 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00174" FT DISULFID 363..442 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00174" FT DISULFID 477..493 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00174" FT DISULFID 525..540 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00174" FT DISULFID 567..587 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00174" FT VAR_SEQ 1..366 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.2" FT /id="VSP_011206" FT CONFLICT 539 FT /note="K -> R (in Ref. 1; BAB13699)" FT /evidence="ECO:0000305" SQ SEQUENCE 603 AA; 68359 MW; 4B5888733D8577CF CRC64; MAVARKIRTL LTVNILVFVG IVLFSVYCRL QGRSQELVRI VSGDRRVRSR HAKVGTLGDR EAILQRLDHL EEVVYNQLNG LAKPIGLVEG PGGLGQGGLA ATLRDDGQEA EGKYEEYGYN AQLSDRISLD RSIPDYRPRK CRQMSYAQDL PQVSVVFIFV NEALSVILRS VHSVVNHTPS QLLKEVILVD DNSDNVELKF NLDQYVNKRY PGLVKIVRNS RREGLIRARL QGWKAATAPV VGFFDAHVEF NTGWAEPALS RIREDRRRIV LPAIDNIKYS TFEVQQYANA AHGYNWGLRC MYIIPPQDWL DRGDESAPIR TPAMIGCSFV VDREYFGDIG LLDPGMEVYG GENVELGMRV WQCGGSMEVL PCSRVAHIER TRKPYNNDID YYAKRNALRA AEVWMDDFKS HVYMAWNIPM SNPGVDFGDV SERLALRQRL KCRSFKWYLE NVYPEMRVYN NTLTYGEVRN SKASAYCLDQ GAEDGDRAIL YPCHGMSSQL VRYSADGLLQ LGPLGSTAFL PDSKCLVDDG TGRMPTLKKC EDVARPTQRL WDFTQSGPIV SRATGRCLEV EMSKDANFGL RLVVQRCSGQ KWMIRNWIKH ARH //